Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06102486 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MCI Speech in Noise

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later across 2 updates May 1, 2026 → Nov 1, 2026
See other at-risk trials from Dartmouth-Hitchcock Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Sep 1, 2026 to Nov 1, 2026
    • Study completion pushed from Sep 2, 2026 to Nov 2, 2026
    • Eligibility criteria expanded, about 19 words
  2. Minor Re-verified, no change to tracked fieldsv9
  3. Minor Primary completion pushed from May 1, 2026 to Sep 1, 2026
    • Study completion pushed from May 2, 2026 to Sep 2, 2026
    v8
  4. Minor Primary completion date: Dec 1, 2025 to May 1, 2026
    • Study completion date: Dec 2, 2025 to May 2, 2026
    v7
  5. Minor Site contact updatedv6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Start date changed from estimate of May 15, 2024 to May 18, 2024v5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 15, 2024 to May 15, 2024
    • Study sites: 0 to 1
    • Eligibility criteria shortened, about 18 words
    v4
  3. Notable Start date: Feb 2024 to Apr 15, 2024
    • Primary completion date: Jun 2025 to Dec 1, 2025
    • Study completion date: Jun 2025 to Dec 2, 2025
    v3
  4. Notable Start date: Nov 2023 to Feb 2024v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether people with MCI (Mild Cognitive Impairment) and healthy comparison subjects differ with respect to their ability to hear soft sounds and how their brain understands and processes sound. The investigators are also evaluating, within those with MCI, whether the hearing tests are associated with neurocognitive functioning. The investigators are interested in learning whether changes in cognition in those with MCI can be detected using tests of how the brain processes sound. The investigators hypothesize that participants with MCI will score worse on both hearing tests and neurocognitive tests than participants without MCI. Participants are asked to complete multiple types of hearing tests, take a series of neurocognitive tests, and complete a few questionnaires.
Trial Details
NCT Number NCT06102486
Lead Sponsor Dartmouth-Hitchcock Medical Center
Collaborators: Dartmouth College
Conditions
(from sponsor)
Mild Cognitive Impairment
Related terms Cognitive Dysfunction
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov